Treatment of Chronic Hepatitis C in Children With Intron Vial or Pen [interferon alfa-2b] and Rebetol [ribavirin] According to German Law (67 Abs 6 AMG).
Phase of Trial: Phase IV
Latest Information Update: 19 Jun 2014
At a glance
- Drugs Interferon alpha-2b (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 02 Sep 2009 Planned end date changed from Oct 2009 to Jun 2007 as reported by ClinicalTrials.gov.
- 02 Sep 2009 Actual number of patients (3) added as reported by ClinicalTrials.gov.
- 20 Aug 2008 New trial record.